Oral GW766944 (Oral CCR3 Antagonist)

Condition:   Asthma
Interventions:   Drug: GW766944;   Other: Placebo
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Tagged on: , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *